Eun Sang Yoo

Eun Sang Yoo

Auto-generated profile, based on publicly available information

Eun Sang Yoo

Department of Urology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Republic of Korea

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SCSo Young Chun
So Young Chun
Shay SokerShay Soker
Shay Soker
YJYu-Jin Jang
Yu-Jin Jang
TKTae Gyun Kwon
Tae Gyun Kwon
EYEun Sang Yoo
Eun Sang Yoo
Chun SY, et al. J Korean Med Sci. 2016 Feb;31(2):171-177. http://dx.doi.org/10.3346/jkms.2016.31.2.171

24 January 2019 in BMC Urology
Verified
Journal Article
Open access
PDF file
YHYun-Sok Ha
Yun-Sok Ha
SKSang Won Kim
Sang Won Kim
SCSo Young Chun
So Young Chun
JCJae-Wook Chung
Jae-Wook Chung
SCSeock Hwan Choi
Seock Hwan Choi
TKTae-Hwan Kim
Tae-Hwan Kim
New biological prognostic predictors have been studied; however, some factors have limited clinical application due to tissue-specific expression and high cost. There is the need for a promising predictive factor that is simple to detect and that is closely linked to oncological outcomes in patients with urothelial bladder cancer (BC) who have undergone radical cystectomy (RC). Therefore, we investigated the clinical prognostic value of the preoperative De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) on oncological outcomes in patients with urothelial BC after RC. We retrospectively evaluated clinicopathological data of 118 patients with non-metastatic urothelial BC after RC between 2008 and 2013 at a single center. The association between the De Ritis ratio and clinicopathological findings was assessed. The potential prognostic value of the De Ritis ratio was analyzed using the Kaplan-Meier method, and multivariate Cox analyses were performed to identify the independent predictors of metastasis-free survival, cancer-specific survival, and overall survival. According to the receiver operating curve of the De Ritis ratio for metastasis, we stratified the patients into 2 groups using a threshold of 1.3. A high De Ritis ratio was more likely to be associated with old age and the female sex. Kaplan-Meier estimates revealed that patients with a high De Ritis ratio had inferior metastasis-free survival, cancer-specific survival, and overall survival outcomes (P = 0.012, 0.024, and 0.022, respectively). Multivariate analysis revealed that a high De Ritis ratio was an independent prognostic factor for metastasis (hazard ratio [HR], 2.389; 95% confidence interval [CI], 1.161–4.914; P = 0.018), cancer-related death (HR, 2.755; 95% CI, 1.214–6.249; P = 0.015), and overall death (HR, 2.761; 95% CI, 1.257–6.067; P = 0.011). An elevated De Ritis ratio was significantly associated with worse prognosis in patients who underwent RC for urothelial BC. This ratio might further improve the predictive accuracy for prognosis in BC.

1 January 2012 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
BKBum Soo Kim
Bum Soo Kim
TKTae-Hwan Kim
Tae-Hwan Kim
TKTae Gyun Kwon
Tae Gyun Kwon
EYEun Sang Yoo
Eun Sang Yoo
Kim BS, et al. Yonsei Med J. 2012 May;53(3):550-556. http://dx.doi.org/10.3349/ymj.2012.53.3.550

30 September 2017 in International Neurourology Journal
Verified
Journal Article
Open access
PDF file
PSPhil Hyun Song
Phil Hyun Song
SCSo Young Chun
So Young Chun
JCJae-Wook Chung
Jae-Wook Chung
YKYeon Yong Kim
Yeon Yong Kim
HLHyo Jung Lee
Hyo Jung Lee
BKBum Soo Kim
Bum Soo Kim
We evaluated 5 different rat models using different agents in order to establish a standard animal model for interstitial cystitis (IC) in terms of the functional and pathologic characteristics of the bladder. Five IC models were generated in 8-week-old female Sprague-Dawley rats via transurethral instillation of 0.1M hydrogen chloride (HCl) or 3% acetic acid (AA), intraperitoneal injection of cyclophosphamide (CYP) or lipopolysaccharide (LPS), or subcutaneous injection of uroplakin II (UPK2). After generating the IC models, conscious cystometry was performed on days 3, 7, and 14. All rats were euthanized on day 14 and their bladders were obtained for histological and pro-inflammatory-related gene expression analysis. In the cystometric analysis, all experimental groups showed significantly decreased intercontraction intervals compared with the control group on day 3, but only the LPS and UPK groups maintained significantly shorter intercontraction intervals than the control group on day 14. The histological analysis revealed that areas with severe urothelial erosion (HCl, AA, and UPK) and hyperplasia (CYP and LPS), particularly in the UPK-treated bladders, showed a markedly increased infiltration of toluidine blue-stained mast cells and increased tissue fibrosis. In addition, significantly elevated expression of interleukin-1b, interleukin-6, myeloperoxidase, monocyte chemotactic protein 1, and Toll-like receptors 2 and 4 was observed in the UPK group compared to the other groups. Among the 5 different agents, the injection of UPK generated the most effective IC animal model, showing consequent urothelial barrier loss, inflammatory reaction, tissue fibrosis stimulation, and persistent hyperactive bladder.

31 March 2017 in International Neurourology Journal
Verified
Journal Article
Open access
PDF file
MWMyeong Jin Woo
Myeong Jin Woo
YHYun-Sok Ha
Yun-Sok Ha
JLJun Nyung Lee
Jun Nyung Lee
BKBum Soo Kim
Bum Soo Kim
HKHyun Tae Kim
Hyun Tae Kim
EYEun Sang Yoo
Eun Sang Yoo
Currently, holmium laser enucleation of the prostate (HoLEP) and transurethral resection of the prostate (TURP) are the standard surgical procedures used to treat benign prostatic hyperplasia (BPH). Several recent studies have demonstrated that the surgical management of BPH in patients with detrusor underactivity (DU) can effectively improve voiding symptoms, but comparative data on the efficacy of HoLEP and TURP are insufficient. Therefore, we compared the short-term surgical outcomes of HoLEP and TURP in patients with DU. From January 2010 to May 2015, 352 patients underwent HoLEP or TURP in procedures performed by a single surgeon. Of these patients, 56 patients with both BPH and DU were enrolled in this study (HoLEP, n=24; TURP, n=32). Surgical outcomes were retrospectively compared between the 2 groups. DU was defined as a detrusor pressure at maximal flow rate of <40 cm H2O as measured by a pressure flow study. The preoperative characteristics of patients and the presence of comorbidities were comparable between the 2 groups. The TURP group showed a significantly shorter operative time than the HoLEP group (P=0.033). The weight of the resected prostate was greater in the HoLEP group, and postoperative voiding parameters, including peak flow rate and postvoid residual urine volume were significantly better in the HoLEP group than in the TURP group. HoLEP can be effectively and safely performed in patients with DU and can be expected to have better surgical outcomes than TURP in terms of the improvement in lower urinary tract symptoms.

1 April 2016 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
JLJun Nyung Lee
Jun Nyung Lee
JLJae-Kwang Lim
Jae-Kwang Lim
MWMyeong Jin Woo
Myeong Jin Woo
SKSe Yun Kwon
Se Yun Kwon
BKBum Soo Kim
Bum Soo Kim
SCSung Kwang Chung
Sung Kwang Chung